Infectious Disease Alert – October 1, 2009
October 1, 2009
View Archives Issues
-
Artemisinins and Malaria: Resistance Already?
Artemisinins are the most rapidly acting antimalarials available, have few serious side effects, and have been used extensively with few reports of resistance until recently. -
Vi Typhoid Vaccine Provides Both Protection in Young Children and Herd Immunity
Typhoid fever sickens more than 16 million people worldwide and causes up to 600,000 deaths annually, mostly in developing countries. -
Prophylactic rG-CSF for Preterm Neonates with Neutropenia
A randomized, double-blind, placebo-controlled, multicenter study was conducted from 2002-2006 at 25 institutions in France of the effect of prophylactic recombinant granulocyte-colony stimulating factor (rG-CSF) on nosocomial infections and survival among preterm neonates with persistent neutropenia. -
New HIV Primary Care Guidelines from IDSA
The 2009 update of hiv primary care guidelines make several new recommendations, and the evidence basis for these is documented in the paper. -
Alternative Dosing of Oseltamivir for Specific Patient Populations: Critically Ill and Renally Impaired
Oseltamivir (tamiflu®) is an fda-approved drug for the treatment and prevention of influenza. -
Updates By Carol A. Kemper, MD, FACP
Epidemiologists have pondered the possible environmental source for sporadic cases of legionella infection in humans. -
Pharmacology Watch: WHO Issues Global Alert on Antiviral Use
n this issue: WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions. -
Clinical Briefs in Primary Care supplement